ArticleScientific reports2023

Sodium-glucose cotransporter-2 inhibitors improve clinical outcomes in patients with type 2 diabetes mellitus undergoing anthracycline-containing chemotherapy: an emulated target trial using nationwide cohort data in South Korea.

Hui-Jeong Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.